Facet browsing currently unavailable
Page 1 of 1 results
Sort by: relevance publication year
Showing DOI matching
10.1007/s10637-019-00890-5
Effectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting JOURNAL ARTICLE published October 2020 in Investigational New Drugs Research funded by Eisai (None) |